Importantly, LIPTER overexpression mitigates cardiomyopathies and preserves cardiac functions in mouse models of obesity and diabetes, highlighting LIPTER’s potential clinical relevance in treating human metabolic syndrome-associated heart disease and failure. This evidence concerns the gene LINC00881 and metabolic syndrome.